Medpace Holdings Inc (MEDP)
307.72
-2.91
(-0.94%)
USD |
NASDAQ |
Nov 18, 12:32
Medpace Holdings Revenue (Quarterly): 533.32M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 533.32M |
| June 30, 2024 | 528.10M |
| March 31, 2024 | 511.04M |
| December 31, 2023 | 498.40M |
| September 30, 2023 | 492.50M |
| June 30, 2023 | 460.87M |
| March 31, 2023 | 434.07M |
| December 31, 2022 | 394.10M |
| September 30, 2022 | 383.74M |
| June 30, 2022 | 351.21M |
| March 31, 2022 | 330.95M |
| December 31, 2021 | 308.55M |
| September 30, 2021 | 295.57M |
| June 30, 2021 | 278.29M |
| March 31, 2021 | 259.96M |
| December 31, 2020 | 259.68M |
| September 30, 2020 | 230.37M |
| June 30, 2020 | 205.00M |
| March 31, 2020 | 230.88M |
| December 31, 2019 | 229.89M |
| Date | Value |
|---|---|
| September 30, 2019 | 216.24M |
| June 30, 2019 | 214.10M |
| March 31, 2019 | 200.74M |
| December 31, 2018 | 192.12M |
| September 30, 2018 | 179.25M |
| June 30, 2018 | 170.14M |
| March 31, 2018 | 163.08M |
| December 31, 2017 | 112.68M |
| September 30, 2017 | 110.64M |
| June 30, 2017 | 106.22M |
| March 31, 2017 | 106.61M |
| December 31, 2016 | 108.24M |
| September 30, 2016 | 107.80M |
| June 30, 2016 | 105.95M |
| March 31, 2016 | 99.59M |
| December 31, 2015 | 96.04M |
| September 30, 2015 | 92.13M |
| June 30, 2015 | 87.85M |
| March 31, 2015 | 83.03M |
| March 31, 2014 | 77.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
205.00M
Minimum
Jun 2020
533.32M
Maximum
Sep 2024
360.82M
Average
341.08M
Median
Revenue (Quarterly) Benchmarks
| Globus Medical Inc | 625.70M |
| IQVIA Holdings Inc | 3.896B |
| Fortrea Holdings Inc | 674.90M |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.05M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 96.43M |
| Total Expenses (Quarterly) | 421.04M |
| EPS Diluted (Quarterly) | 3.01 |
| Enterprise Value | 8.998B |
| Gross Profit Margin (Quarterly) | 31.69% |
| Profit Margin (Quarterly) | 18.08% |
| Earnings Yield | 3.71% |
| Operating Earnings Yield | 4.15% |
| Normalized Earnings Yield | 3.711 |